Immunic, Inc. (FRA:10VA)
Germany
· Delayed Price · Currency is EUR 0.574
+0.006 (1.06%)
At close: Dec 4, 2025
Immunic Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2016 |
| Cash & Equivalents | 35.13 | 35.67 | 46.67 | 106.75 | 86.86 | 127.45 | Upgrade
|
| Short-Term Investments | - | - | - | 9.63 | - | - | Upgrade
|
| Cash & Short-Term Investments | 35.13 | 35.67 | 46.67 | 116.37 | 86.86 | 127.45 | Upgrade
|
| Cash Growth | -40.53% | -23.58% | -59.89% | 33.97% | -31.85% | 333.97% | Upgrade
|
| Other Receivables | 0.18 | 0.68 | 2.48 | 2.66 | 2.15 | 1.64 | Upgrade
|
| Receivables | 0.18 | 0.68 | 2.48 | 2.66 | 2.15 | 1.64 | Upgrade
|
| Prepaid Expenses | 3.15 | 1.87 | 2.31 | 5.61 | 15.98 | 4.65 | Upgrade
|
| Other Current Assets | 0.82 | 1.11 | 1.07 | 1.23 | - | - | Upgrade
|
| Total Current Assets | 39.27 | 39.33 | 52.53 | 125.86 | 104.99 | 133.75 | Upgrade
|
| Property, Plant & Equipment | 1.43 | 1.54 | 1.77 | 1.85 | 1.1 | 1.1 | Upgrade
|
| Goodwill | - | - | - | - | 32.97 | 32.97 | Upgrade
|
| Other Long-Term Assets | - | - | - | 0.04 | 0.04 | 0.04 | Upgrade
|
| Total Assets | 40.7 | 40.87 | 54.3 | 127.75 | 139.1 | 167.86 | Upgrade
|
| Accounts Payable | 7.92 | 7.85 | 5.1 | 4.28 | 3.75 | 3.7 | Upgrade
|
| Accrued Expenses | 19.45 | 12.91 | 18.66 | 7.99 | 7.07 | 4.32 | Upgrade
|
| Current Portion of Leases | 0.67 | 0.74 | 0.7 | 0.57 | 0.41 | 0.3 | Upgrade
|
| Other Current Liabilities | 2.04 | 0.68 | 0.27 | 0.24 | 0.18 | 0.08 | Upgrade
|
| Total Current Liabilities | 30.08 | 22.18 | 24.73 | 13.08 | 11.4 | 8.4 | Upgrade
|
| Long-Term Leases | 0.13 | 0.26 | 0.64 | 0.99 | 0.58 | 0.68 | Upgrade
|
| Total Liabilities | 30.21 | 22.44 | 25.37 | 14.07 | 11.99 | 9.08 | Upgrade
|
| Common Stock | 0.01 | 0.01 | 0 | 0 | 0 | 0 | Upgrade
|
| Additional Paid-In Capital | 597.18 | 525.61 | 436.06 | 427.93 | 324.24 | 266.82 | Upgrade
|
| Retained Earnings | -589.27 | -511.4 | -410.89 | -317.28 | -196.87 | -103.93 | Upgrade
|
| Comprehensive Income & Other | 2.58 | 4.21 | 3.76 | 3.04 | -0.25 | -4.11 | Upgrade
|
| Total Common Equity | 10.5 | 18.43 | 28.93 | 113.68 | 127.12 | 158.79 | Upgrade
|
| Shareholders' Equity | 10.5 | 18.43 | 28.93 | 113.68 | 127.12 | 158.79 | Upgrade
|
| Total Liabilities & Equity | 40.7 | 40.87 | 54.3 | 127.75 | 139.1 | 167.86 | Upgrade
|
| Total Debt | 0.79 | 1 | 1.33 | 1.56 | 0.99 | 0.98 | Upgrade
|
| Net Cash (Debt) | 34.34 | 34.66 | 45.34 | 114.81 | 85.87 | 126.48 | Upgrade
|
| Net Cash Growth | -40.97% | -23.55% | -60.51% | 33.70% | -32.10% | 338.41% | Upgrade
|
| Net Cash Per Share | 0.26 | 0.35 | 1.02 | 3.61 | 3.63 | 8.07 | Upgrade
|
| Filing Date Shares Outstanding | 120.28 | 90.15 | 89.93 | 44.4 | 27.91 | 21.17 | Upgrade
|
| Total Common Shares Outstanding | 98.65 | 90.15 | 45.18 | 39.31 | 26.34 | 21.17 | Upgrade
|
| Working Capital | 9.19 | 17.16 | 27.81 | 112.79 | 93.59 | 125.35 | Upgrade
|
| Book Value Per Share | 0.11 | 0.20 | 0.64 | 2.89 | 4.83 | 7.50 | Upgrade
|
| Tangible Book Value | 10.5 | 18.43 | 28.93 | 113.68 | 94.15 | 125.82 | Upgrade
|
| Tangible Book Value Per Share | 0.11 | 0.20 | 0.64 | 2.89 | 3.57 | 5.94 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.